Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Register now for the “Q4 Earnings Season Wrap-Up.”
Join stock market expert Marc Chaikin (the creator of Chaikin Money Flow) and Explosive Options’ Bob Lang for a special earnings season wrap-up.

You’ll find out the biggest takeaways from recent earnings results and what it means for the market—and YOUR money. 

Menu

Obesity ETF (SLIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family JANUS
  • Assets Under Management 13,838,000
  • Market Capitalization, $K 13,838
  • Shares Outstanding, K 400
  • 36-Month Beta 0.98
  • Price/Book 13.73
  • Price/Earnings ttm 26.23
  • Annual Dividend & Yield 0.14 (0.42%)
  • Most Recent Dividend 0.007 on 12/20/18
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.11 +7.29%
on 01/29/19
34.99 -1.54%
on 02/19/19
+0.60 (+1.77%)
since 01/18/19
3-Month
29.78 +15.66%
on 12/24/18
34.99 -1.54%
on 02/19/19
+2.20 (+6.82%)
since 11/21/18
52-Week
29.78 +15.66%
on 12/24/18
40.01 -13.90%
on 08/08/18
+2.05 (+6.33%)
since 02/21/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade SLIM with:

Fund Summary

The Obesity ETF seeks investment results that correspond generally, before fees and expenses, to the performance of the Solactive Obesity Index.

See More

Top 10 Holdings

Name % Holdings
Fresenius Medical Care AG & Co KGaA 8.06%
ABIOMED Inc 7.55%
ResMed Inc (CDI) 6.86%
DexCom Inc 6.32%
Insulet Corp 5.14%
DaVita Inc 4.44%
Herbalife Nuition Ltd 4.20%
Fisher & Paykel Healthcare Corp Ltd 4.18%
Tandem Diabetes Care Inc 3.27%
Arena Pharmaceuticals Inc 3.04%

See More

Key Turning Points

2nd Resistance Point 35.03
1st Resistance Point 34.77
Last Price 34.45
1st Support Level 34.39
2nd Support Level 34.27

See More

52-Week High 40.01
Fibonacci 61.8% 36.10
Fibonacci 50% 34.90
Last Price 34.45
Fibonacci 38.2% 33.69
52-Week Low 29.78

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar